April 21, 2026
Projections indicate that, biological therapies industry is projected to rise from USD 458.47 billion in 2024 to USD 1107.66 billion by 2034, reflecting a CAGR of 9.35% over the next decade. The biological therapies market is rising due to the rising...
June 23, 2026
According to Rohan Patil, who specializes in sterility assurance solutions, biological validation systems, and microbial performance indicators, with 5+ years of experience in market research and industry analysis, extensive research indicates strong...
April 21, 2026
Polymerase chain reaction (PCR) is a DNA amplification method widely used in diagnostics and biotechnology. In 2022, India conducted 600-700 million diagnostic tests, adding 1,390 biotech startups. PCR enzymes drive efficiency and sustainability. The...
April 21, 2026
Based on market forecasts, the global veterinary biological product market, projected at USD 17.9 billion in 2024, is expected to reach USD 25.9 billion by 2034, growing at a CAGR of 3.78% over the forecast period. The critical role of veterinary pro...
April 21, 2026
Market insights predict the global biological and chemical indicators industry will increase from USD 570.67 million in 2024 to USD 942.03 million by 2034, achieving a CAGR of 5.14%. The growing need for sterilization in the healthcare sector is a cr...
May 18, 2026
Proteomics Market (By Product & Services: Reagents & Consumables, Services, Instruments; By Technology: Spectrometry, Next-generation Sequencing, Microarray Instruments, X-Ray Crystallography, Chromatography, Protein Fractionation Systems, El...
April 20, 2026
Biological Safety Cabinet Market (By Product: Class I, Class II, Class II Type A, Class II Type B, Class III; By End-Use: Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations;...
March 24, 2026
Based on our market forecasts, the biological sample temperature-controlled storage services sector will expand from USD 624 billion in 2025 to USD 1843.3 million by 2035, experiencing a CAGR of 11.44%. The biological sample temperature-controlled st...
April 21, 2026
Projections indicate that, the global biological safety testing market will increase from USD 5.43 billion in 2024 to USD 15.07 billion by 2034, experiencing a CAGR of 10.75% over the next 10 years. The Growing concern regarding the safety of product...
April 21, 2026
According to market projections, the global biological inactivated vaccine market, valued at USD 0.95 billion in 2024, is anticipated to reach USD 1.57 billion by 2034, growing at a CAGR of 5.14% over the next decade.The rising prevalence of infect...
April 21, 2026
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, ...
April 21, 2026
Market insights predict, the cartilage repair industry is expected to grow from USD 1.51 billion in 2024 to USD 7.32 billion by 2034, driven by a CAGR of 17.14%. The cartilage repair market is growing due to the rising geriatric population. Nor...
March 31, 2026
Cancer Biomarkers Market (By Type: Breast cancer, Prostate cancer, Colorectal cancer, Cervical cancer, Liver cancer, Lung cancer, Others; By Biomolecule: Genetic Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Proteomic Biomarkers, Others; B...
February 10, 2026
Based on our forecasts, the iPSC cell therapies market was valued at USD 10.44 billion in 2025 and is expected to reach USD 11.64 billion by 2026, growing steadily to approximately USD 30.87 billion by 2035 at a CAGR of 11.45% during the forecast per...
April 21, 2026
Market insights predict the U.S. pharmaceutical industry will increase from USD 520.4 billion in 2025 to USD 965 billion by 2035, achieving a CAGR of 6.37%. The strong presence of pharmaceutical companies and favorable regulatory support bolsters mar...
April 21, 2026
The HIV PrEP market is expanding due to its growing approvals as well as rising long-acting injectable PrEP innovations. North America led the market due to the early adoption of the HIV PrEP....
April 21, 2026
According to market projections, the CRISPR technology sector is expected to grow from USD 5.72 billion in 2024 to USD 26.22 billion by 2034, reflecting a CAGR of 16.54%. In 2024, North America led the global CRISPR technology market, while Asia-Paci...
January 12, 2026
According to market projections, the huntington's disease treatment sector is expected to grow from USD 716.76 million in 2025 to USD 1519.02 million by 2035, reflecting a CAGR of 7.8%. Huntington's disease treatment focuses on managing symptoms, as ...
January 09, 2026
According to our research, the mental health medications market was valued at USD 24.25 billion in 2025 and is projected to grow from USD 25.76 billion in 2026 to USD 44.26 billion by 2035, registering a CAGR of 6.2% during 2026 to 2035....
April 21, 2026
Based on market forecasts, the U.S. osteoarthritis therapeutics market, projected at USD 3.27 billion in 2024, is expected to reach USD 6.46 billion by 2034, growing at a CAGR of 7.14% over the forecast period. The severe disease burden, the limited ...
February 24, 2026
Market insights predict the global antibody drug conjugate (ADC) industry will increase from USD 13.51 billion in 2025 to USD 32.66 billion by 2035, achieving a CAGR of 9.23%. The rising number of cancer cases and the rising need for safe, efficient ...
April 21, 2026
According to market projections, the cardiometabolic diseases market was valued at USD 292.04 billion in 2026 and is projected to reach approximately USD 1,987.69 billion by 2035, growing at a strong CAGR of 23.75% from 2026 to 2035. The cardiometabo...
April 21, 2026
Market insights predict, the branded generics industry is expected to grow from USD 383.1 billion in 2025 to USD 867.21 billion by 2035, driven by a CAGR of 8.47%. The branded generics market is growing due to the rising prevalence of chronic health ...
January 16, 2026
Our projections indicate, the U.S. Cell and Gene Therapy CDMO market is experiencing exponential growth driven by expanding clinical pipelines and increasing outsourcing of complex biologics manufacturing. With revenues projected to rise from USD 4.0...
April 21, 2026
The next-generation metabolic therapies market is witnessing strong expansion and is expected to generate revenue in the hundreds of millions during the forecast period from 2026 to 2035, driven by rising cases of metabolic disorders such as obesity,...
April 21, 2026
According to forecasts, the global alopecia areata market will grow from USD 3.32 billion in 2024 to USD 6.92 billion by 2034, with an expected CAGR of 7.6%. AI is transforming the Alopecia Areata market by improving diagnosis, treatment, and researc...
April 21, 2026
The behavioral mental health market is expanding due to growing digital platforms as well as increasing use of ketamine therapies. North America led the market due to the presence of a strong healthcare sector....
April 21, 2026
Market insights predict, the gRNA industry is expected to grow from USD 592.66 million in 2024 to USD 3,296.45 million by 2034, driven by a CAGR of 18.72%. Growing research in genomics due to rare diseases and gene and cell therapy drives the use of ...
April 21, 2026
The AI-based pharmaceutical R&D services market is growing due to rising demand for automation. North America’s dominance can be attributed to the rising R&D in developing novel therapeutics....
April 21, 2026
According to market projections, the hemophilia sector is expected to grow from USD 14.34 billion in 2024 to USD 27.27 billion by 2034, reflecting a CAGR of 6.64%. Hemophilia affects over 1.1M globally, often undiagnosed. Advances like gene therapy a...
April 27, 2026
U.S. Bispecific Antibody Market (By Therapeutic Area/Indication: Oncology, Immuno-inflammation/Autoimmunity, Infectious Diseases, Ophthalmology/Rare Diseases/Others; By Format/Architecture: Dual-variable/IgG-based bispecifics, T-cell Engagers, Bispec...
April 09, 2026
Drugs Market ( By Product Type: Prescription Drugs Over-the-Counter (OTC) Drugs; By Therapeutic Area: Oncology, Cardiovascular, Central Nervous System, Respiratory, Infectious Diseases, Gastrointestinal, Diabetes, Autoimmune Disorders, Dermatology, O...
April 21, 2026
Market insights predict, the human platelet lysate industry is expected to grow from USD 587 million in 2025 to USD 2416 million by 2035, driven by a CAGR of 15.19%. The human platelet lysate market is growing due to the rising usage in developing ce...
April 21, 2026
According to market projections, the gene therapies for cancer treatment sector is expected to grow from USD 8.28 billion in 2024 to USD 238.77 billion by 2034, reflecting a CAGR of 39.94%. The rising prevalence of cancer and the growing demand for p...
January 29, 2026
According to forecasts, the global nanoparticle synthesis system market will grow from USD 0.78 billion in 2025 to USD 2.28 billion by 2035, with an expected CAGR of 11.34%. The nanoparticle synthesis system market is growing because nanoparticle syn...
April 24, 2026
Biosimilar Monoclonal Antibodies Market (By Type: Adalimumab, Bevacizumab, Infliximab, Rituximab, Trastuzumab, Others; By Indication: Oncology, Autoimmune diseases, Others; By End User: Hospitals, Cancer treatment centers, Others; By Region: North Am...
April 21, 2026
According to forecasts, the global myasthenia gravis treatment market will grow from USD 1.55 billion in 2024 to USD 3.29 billion by 2034, with an expected CAGR of 7.84%. The myasthenia gravis treatment market is growing due to the rising prevalence ...
April 21, 2026
The exosome cell and gene therapy market is booming, driven by its use in treating cancer, rare, and genetic diseases. With tech like AI and automation, personalized therapies are improving care. North America leads, while Asia Pacific sees rapid gro...
April 21, 2026
Market insights predict the global bipolar disorder treatment industry will increase from USD 9.24 billion in 2024 to USD 15.67 billion by 2034, achieving a CAGR of 5.43%. In 2024, North America led the bipolar disorder treatment market, while Asia-P...
May 28, 2026
Poly-L-Lactic Acid Filler Market (By Product Type: Injectable PLLA Fillers, Combination Fillers; By Application: Facial Aesthetics, Body Contouring, Medical Applications; By End User: Dermatology Clinics, Cosmetic Surgery Centers, Hospitals, Medical ...
April 21, 2026
According to market projections, the U.S. clinical trials sector is expected to grow from USD 43.45 billion in 2025 to USD 80.42 billion by 2035, reflecting a CAGR of 6.35%. The U.S. clinical trials market is growing due to rising government investme...
April 20, 2026
According to forecasts, the North America cell and gene therapy market will grow from USD 4.46 billion in 2025 to USD 21.7 billion by 2035, with an expected CAGR of 17.1%. The North America cell and gene therapy market is growing due to the rising de...
January 20, 2026
Based on market forecasts, the personalized medicine sector will expand from USD 620.14 billion in 2025 to USD 1368.89 billion by 2035, experiencing a CAGR of 8.24%. The ever-increasing personalized medicine market, due to personalized medicine, aims...
April 02, 2026
Valves in Pharmaceutical Market (By Valve Type: Diaphragm Valves, Ball Valves, Butterfly Valves, Control Valves, Check & Safety Valves, Others; By Material: Stainless Steel, Alloys, Polymers & Plastics, Other Materials; By Application: Tradit...
April 21, 2026
Projections indicate that, AI in pharmaceuticals industry is projected to rise from USD 1.97 billion in 2025 to USD 21.51 billion by 2035, reflecting a CAGR of 27.01% over the next decade. The AI in the pharmaceutical market is growing as demand for ...
April 21, 2026
According to market projections, the antimalarial drugs sector is expected to grow from USD 1.07 billion in 2024 to USD 1.67 billion by 2034, reflecting a CAGR of 4.57%. Establishing awareness and government programs are propelling the global market ...
May 20, 2026
Inhalable Biologics Market (By Type: Peptides and Proteins, Vaccines, Monoclonal Antibodies, RNAi-based Therapeutics, Others; By Application: Respiratory diseases, COPD, Asthma, Cystic Fibrosis, COVID-19, Others, Diabetes, Cancer, Others; By Dosage F...
May 27, 2026
China Pharmaceutical Market (By Drug Type: Branded Drugs, Generic Drugs, Biopharmaceuticals, OTC Drugs; By Product type: Prescription Drugs, Over-the-Counter Drugs; By Molecule Type: Small Molecules, Large Molecules; By Therapeutic Area: Oncology, Ca...
May 21, 2026
North America Pharmaceutical Market (By Product Type: Branded small-molecule innovative drugs, Biologics & Monoclonal Antibodies, Generics, Specialty medicines/orphan drugs & advanced therapies, Vaccines, Over-the-counter (OTC) medicines, Bio...
March 25, 2026
U.S. CAR T-Cell Therapies Market (By Drug Type: Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Others; By Indication: Lymphoma, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Others; By E...
April 21, 2026
The advanced therapies in biopharmaceutical medicine market is expanding due to increasing diseases as well as growing gene editing therapies. North America led the market due to the presence of a well-developed healthcare sector....
April 21, 2026
According to market projections, the global pulmonary arterial hypertension drugs market, valued at USD 8.04 billion in 2024, is anticipated to reach USD 12.38 billion by 2034, growing at a CAGR of 4.44% over the next decade. The market is growing du...
April 17, 2026
Hyper-Personalized Medicine Market (By Product: Diagnostics, Therapeutics, Medical Care, Nutrition & Wellness; By Technology: Genomics, Proteomics, Bioinformatics, Metabolomics, Artificial Intelligence (AI); By Application: Oncology, Cardiology, ...
April 30, 2026
Biosimilar Antibodies Market (By Molecular Type: Monoclonal Antibodies (mAbs), Fusion Proteins; By Application: Oncology, Autoimmune Diseases, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; By Region: Nort...
April 21, 2026
Market insights predict the global biotechnology industry will increase to USD 5666.02 billion by 2035 rapidly fueled by breakthroughs in healthcare, agriculture, and industry. With a 12.5% CAGR over the next decade, innovations in gene therapy, CRIS...
April 21, 2026
According to market projections, the DNA vaccine sector is expected to grow from USD 553.89 million in 2024 to USD 1041.68 million by 2034, reflecting a CAGR of 6.52%. In 2024, North America led the global DNA vaccine market, with Asia-Pacific expect...
May 20, 2026
Cell and Gene Therapy for Oncology Market (By Therapy Type: Cell Therapy, Gene Therapy, Non-Viral Gene Therapy, Gene Editing Therapy; By Cancer Type: Hematological Malignancies, Solid Tumors; By Therapy Source: Autologous Therapies, Allogeneic Therap...
April 21, 2026
Due to the increasing burden of diverse cancer cases and demand for advanced chemotherapy drugs and services, the global market is expanding. The presence of advanced healthcare infrastructure and the growing demand for customized cancer care are d...
April 21, 2026
Market insights predict the global cellular reprogramming tools industry will increase from USD 456.1 million in 2024 to USD 760.1 million by 2034, achieving a CAGR of 5.24%. The market is growing due to rising demand for regenerative medicine and pe...
April 21, 2026
Based on market forecasts, the autologous stem cell & non-stem cell therapies sector will expand from USD 5.15 billion in 2024 to USD 82.32 billion by 2034, experiencing a CAGR of 32.26%. The autologous stem cell & non-stem cell therapies m...
April 21, 2026
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...
April 21, 2026
According to forecasts, the global Cell-Based Immunotherapies market will grow from USD 4.59 billion in 2024 to USD 18.62 billion by 2034, with an expected CAGR of 15.02%. The cell-based immunotherapies market is growing due to rising cancer incidenc...
+1 9197 992 333
+91 93077 85324
